Skip to main content
. 2021 Jul 30;100(30):e26722. doi: 10.1097/MD.0000000000026722

Table 6.

Results of individual or combined treatment goals achieved for the T2DM patients in different studies and also stratified according to sex and age.

Studies BP < 130/80 mm Hg (%) HbA1c < 7% (%) LDL-C < 2.6 mmol/l (%) BP < 130/80 mm Hg, HbA1c < 7%, and LDL-C < 2.6 mmol/l (%) BP < 140/90 mm Hg (%) BP < 140/90 mm Hg, HbA1c < 7%, and LDL-C < 2.6 mmol/l (%) Study design
Xu[2] 39.7 A national wide, complex, multistage, probability sampling design
 Gao[26] 36.7 National wide, community-based study
 Ji[12] 28.4 47.7 42.9 5.6 Patients from endocrinology, cardiology, nephrology, and internal medicine clinics in Tier 1–3 hospitals
Lv[33] Newly diagnosed T2DM patients from Tier 1–3 hospitals
 <65 33.5 37 44.3 11.1
 ≥65 47.8 39.4 44.9 13.5
 Xu[32] 25.9 4.5 6 tertiary hospitals across Shaanxi province
Vinagre[35] 31.7 56.1 37.9 12.1 All patients with T2DM treated at the Catalan Health Institute, who were nearly free of charge
 <65 33.3 51.8 32.8 11.9
 ≥65 30.9 58.5 40.6 12.1
 Male 32 55.8 41.3 13.3
 Female 31.4 56.5 34.2 9.9
Braga[36] 54 53 64 21 Primary care physicians were instructed to enroll T2DM patients
Wong ND[34] 34.2–52.8 35–55.5 37–54.4 2.5–24.9 NHANES 1999–2010
Our study 27.8 26.5 42.6 4.1 60.9 8.5
 <65 29.3 25.5 41.6 4 63.4 8.4
 ≥65 24.3 29 44.9 4.3 55.3 8.9
 Male 26.7 26.1 46 4
 Female 29.2 27 38.3 4.2